Managers / Q1 2025 · view latest →
Arlington Trust Co LLC
CIK 0001997685 · 2000 MORRIS AVENUE, SUITE 1300, BIRMINGHAM, AL, 35203 · 2054884300
Summary
Arlington Trust Co LLC reported $472M in U.S.-listed holdings across 615 positions for Q1 2025.
Its largest position, Vanguard High Dividend Yield Index Etf, represents 12.0% of the portfolio.
Compared with Q4 2024, the fund opened 87 new positions and exited 23.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 67.5% · $318M
- Common Stock · 31.3% · $147M
- Other · 0.5% · $2M
- REIT · 0.3% · $2M
- MLP · 0.2% · $836,406
- Other · 0.3% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Fidelity MSCI Info Tech ETF | NEW | +975 | 975 | +$157,238 | $157,238 |
| PIMCO Enhanced Short Maturity Strategy ETF | NEW | +1.5K | 1.5K | +$152,339 | $152,339 |
| XLBSPDR Materials Select Sector | NEW | +1.7K | 1.7K | +$146,166 | $146,166 |
| iShares MSCI United Kingdom ETF | NEW | +3.3K | 3.3K | +$122,602 | $122,602 |
| Goldman Sachs Equal Weight US Equity ETF | NEW | +1.4K | 1.4K | +$106,076 | $106,076 |
| Fidelity Health Care ETF | NEW | +1.4K | 1.4K | +$95,648 | $95,648 |
| Schwab US Dividend Equity ETF | NEW | +3.0K | 3.0K | +$83,880 | $83,880 |
| Schwab 1000 Index ETF | NEW | +3.1K | 3.1K | +$83,452 | $83,452 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2026 | $1.2B | 846 | Jul 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q1 2026 | $1.1B | 844 | Apr 8, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $981M | 431 | Jan 30, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $556M | 585 | Oct 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $512M | 700 | Jul 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $472M | 615 | Apr 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $477M | 551 | Jan 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $459M | 554 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $425M | 534 | Aug 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $389M | 494 | Apr 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $357M | 910 | Jan 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $244M | 323 | Oct 24, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.